Strap in, hold onto your hats and grab a glass of wine. This is a long article. And it's very important. Coincidence? Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology Monday, August 08, 2022 - 06:45am On blood Blood. Ahh blood.

An integrated multiprotein nanopore has been fabricated using components from all three domains of life. This molecular machine opens the door to two approaches in single-molecule protein analysis, in which selected substrate proteins are unfolded, fed to into the proteasomal chamber and then processed either as fragmented peptides or intact polypeptides.

Posted on 6 February 2020 New research has deciphered how rogue communications in blood stem cells can cause Leukaemia. The discovery could pave the way for new, targeted medical treatments that block this process. Blood cancers like leukaemia occur when mutations in stem cells cause them to produce too many blood cells.